Skip to main content
Premium Trial:

Request an Annual Quote

Roche Grants Merck Access to p53 Chip

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Roche Molecular Systems today said that it has formed a research collaboration with Merck subsidiary Merck Sharp & Dohme, under which the drug firm will have access to Roche's microarray-based AmpliChip p53 Test for research purposes.

The chip, which utilizes Affymetrix's microarray technology, is designed to detect mutations in the tumor suppressor gene p53. The test could potentially lead to better treatment outcomes for cancer patients by determining which patients would most likely respond to investigational drug candidates.

Terms of the alliance were not disclosed.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.